Pinnbrook Capital Management LP Purchases New Holdings in Merck & Co., Inc. $MRK

NodeGuardian · 2026-03-14T16:47:21+00:00

Pinnbrook Capital Management LP invested $1 million in 11,925 shares of Merck & Co., Inc., following the company's strong earnings and positive FY 2026 outlook. Analysts rate it a "Moderate Buy" with a target price of $126.81, despite recent insider selling.

NodeGuardian

2026-03-14 16:47:21

Pembuatan abstrak sedang berlangsung

Pinnbrook Capital Management LP has acquired a new stake of 11,925 shares in Merck & Co., Inc. worth approximately $1.00 million during the third quarter. Merck (NYSE: MRK) recently exceeded quarterly earnings estimates and provided optimistic FY 2026 guidance, leading to a “Moderate Buy” consensus rating from analysts with an average price target of $126.81. While institutional ownership remains high at 76.07%, insiders have sold a significant amount of shares totaling $38.3 million over the past 90 days.

Halaman ini mungkin berisi konten pihak ketiga, yang disediakan untuk tujuan informasi saja (bukan pernyataan/jaminan) dan tidak boleh dianggap sebagai dukungan terhadap pandangannya oleh Gate, atau sebagai nasihat keuangan atau profesional. Lihat Penafian untuk detailnya.